Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2009
08/12/2009EP2086641A2 Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders
08/12/2009EP2086589A2 Ultrasound microbubble mediated genes delivery system
08/12/2009EP2086586A2 Anti-microorganism terpenic composition
08/12/2009EP2086570A1 Use of beta-lactamase
08/12/2009EP2086554A2 Methods and compositions for treatment of skin conditions
08/12/2009EP2086553A1 Inhibition of degradation of extracellular matrix
08/12/2009EP2086552A2 Azithromycin for the treatment of nodular acne
08/12/2009EP2086551A2 Thrombopoietin mimetics
08/12/2009EP2086550A2 Estrogen/ serm and estrogen/ progestin bi-layer tablets
08/12/2009EP2086549A1 Therapeutic combination of a panher/vegfr2 kinase inhibitor and a platinum compound
08/12/2009EP2086547A2 Solid forms of (3'-chlorobiphenyl-4-yl)(1-(pyrimidin-2-yl)piperidin-4-yl)methanone and methods of their use
08/12/2009EP2086546A2 Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties
08/12/2009EP2086545A2 Use of 3-alpha-androstanediol, optionally in combination with a pde5 inhibitor, in the treatment of sexual dysfunction
08/12/2009EP2086543A2 Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
08/12/2009EP2086542A1 Topical formulations
08/12/2009EP2086541A2 Compositions for reducing nicotine withdrawal symptoms and/or tobacco usage
08/12/2009EP2086540A1 Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases
08/12/2009EP2086539A1 Selective glycosidase inhibitors
08/12/2009EP2086538A2 Combination therapies for treating alzheimer's disease using i.a. dimebon and dolepezil
08/12/2009EP2086537A1 Imidazo[2, 1-b]thiazoles and their use as pharmaceuticals
08/12/2009EP2086536A1 The use of pramipexole or a salt thereof for the treatment of parkinson's disease
08/12/2009EP2086535A2 Angiotensin ii receptor antagonist for the treatment of systemic diseases in cats
08/12/2009EP2086534A1 Compounds, compositions and methods for controlling invertebrate pests
08/12/2009EP2086533A2 Use of an adenosine antagonist
08/12/2009EP2086532A1 Use for treating obesity and diabetes
08/12/2009EP2086531A1 Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulators
08/12/2009EP2086530A1 Use of gabapentin and pregabalin prodrugs for treating tinnitus
08/12/2009EP2086529A2 Antimicrobial compositions and related applications
08/12/2009EP2086528A2 Na+/k+-atpase-specific peptide inhibitors/activators of src and src family kinases
08/12/2009EP2086527A2 Systems for effecting cessation of tobacco use
08/12/2009EP2086525A1 Method of radio-sensitizing tumors using a radio-sensitizing agent
08/12/2009EP2086524A1 Transnasal anticonvulsive pharmaceutical composition
08/12/2009EP2086522A2 Transdermal therapeutic system comprising norelgestromin for contraception and hormone replacement
08/12/2009EP2086520A1 Imatinib compositions
08/12/2009EP2086519A1 Controlled release complex composition comprising angiotensin-ii-receptor blockers and hmg-coa reductase inhibitors
08/12/2009EP2086518A2 Darusentan oral dosage form
08/12/2009EP2086516A1 Melt-processed imatinib dosage form
08/12/2009EP2086515A2 Rate-controlled bioadhesive oral dosage formulations
08/12/2009EP2086514A2 Pharmaceutical compositions comprising an s1p modulator
08/12/2009EP2086510A1 Preparation of a free flowing molecular dispersion of clopidogrel base
08/12/2009EP2086509A1 Escitalopram and solid pharmaceutical composition comprising the same
08/12/2009EP2086505A2 Injectable depot composition and its process of preparation
08/12/2009EP2086504A2 Diclofenac gel
08/12/2009EP2086503A2 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
08/12/2009EP2086498A2 Eyelid scrub composition
08/12/2009EP2086330A2 Biphosphonate inhalant formulations and methods for using the same
08/12/2009EP2086329A2 Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
08/12/2009EP2086328A2 Novel arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
08/12/2009EP2086326A2 Cyclohexenyl-aryl compounds for inflammation and immune-related uses
08/12/2009EP2086324A2 Heterocyclyl-substituted anti-hypercholesterolemic compounds
08/12/2009EP2086320A2 Compositions and methods for treating jellyfish stings
08/12/2009EP2086317A2 Nicotine formulations, kits and systems and methods for their use
08/12/2009EP2086316A2 Subunguicide, and method for treating onychomycosis
08/12/2009EP1998767A4 Method for promoting composite tissue regeneration and uses thereof
08/12/2009EP1981886B1 7h-pyrido[3,4-d]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors
08/12/2009EP1931348A4 Monocyclic and bicyclic compounds and methods of use
08/12/2009EP1926391B1 Combination of bioavailable methionine with at least one essential oil
08/12/2009EP1904493A4 Tetrahydroprotoberberine compounds, the synthetic method and the use thereof
08/12/2009EP1904461B1 Cyclic anilino-pyridinotriazines as gsk-3 inhibitors
08/12/2009EP1904077B1 Modulating responsiveness to steroids
08/12/2009EP1885695B8 Indoline compounds
08/12/2009EP1874748B1 2 -aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitor (iap) modulators
08/12/2009EP1850827A4 Composition for treating and preventing periodontal disease and method of use
08/12/2009EP1831209B1 Cdc25 phosphatase inhibitors
08/12/2009EP1804780A4 Medium-chain length fatty alcohols as stimulators of hematopoiesis
08/12/2009EP1778686B9 Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors
08/12/2009EP1756135B1 Ester linked macrolides useful for the treatment of microbial infections
08/12/2009EP1756096B1 Indolyl derivatives as liver-x-receptor modulators
08/12/2009EP1747000A4 Ethanol extraction of phytosterols from corn fiber
08/12/2009EP1720518B1 Alginate viscoelastic composition, method of use and package
08/12/2009EP1711508B8 6r-(3,6-dideoxy-l-arabino-hexopyranosyloxy)heptanoic acid, preparation process for the same and dauer effect thereof
08/12/2009EP1682121B1 Use of crth2 antagonist compounds in therapy
08/12/2009EP1682107B1 Anti-tumour terpene compounds
08/12/2009EP1663238B1 HEXA- AND OCTAHYDRO-PYRIDO[1,2-a] PYRAZINE DERIVATIVES WITH NK1 ANTAGONISTIC ACTIVITY
08/12/2009EP1636221B1 3-Heterocyclyl-Azetidine compounds useful as NK1/NK2 receptors antagonists
08/12/2009EP1631291B1 Use of tyrosine kinase inhibitors to treat diabetes
08/12/2009EP1624868B9 "(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)- propyl]phenyl derivatives as beta2 agonists
08/12/2009EP1601346B1 Method for producing a pharmaceutical composition in the form of fibrate-containing tablets and tablets produced by said method
08/12/2009EP1567150B1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics
08/12/2009EP1515959B1 Pharmaceutical salts of reboxetine
08/12/2009EP1515714B1 Long chain unsaturated oxygenated compounds and their use in the therapeutical, cosmetic and nutraceutical field
08/12/2009EP1514116B1 Oxaliplatin anti-resistance method
08/12/2009EP1509529B1 Esters in position 20 of camptothecins
08/12/2009EP1503756B1 Epothilone derivative for the treatment of hepatoma and other cancer diseases
08/12/2009EP1501774B1 Polyunsaturated linear aldehydes and their derivatives with anti-radical activity
08/12/2009EP1496866B1 Process for preparing tannate liquid and semi-solid dosage forms
08/12/2009EP1465912B9 Chimeric tnf ligands
08/12/2009EP1463735B1 Imidazo¬2,1-b -1,3,4-thiadiazole sulfonamides
08/12/2009EP1429771B1 Bicyclic compounds as inhibitors of chemokine binding to us28
08/12/2009EP1427415B1 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
08/12/2009EP1424895B1 Method for expression of small antiviral rna molecules within a cell
08/12/2009EP1423105B9 Combinations of dmxaa and other anti-cancer agents
08/12/2009EP1416048B1 Nucleic acid participating in the formation of presenilin-2-gene exon 5-defective splicing variant
08/12/2009EP1401376A4 Colloidal metal compositions and methods
08/12/2009EP1392328B1 Medicament for protection in radiotherapy
08/12/2009EP1385514B9 Spiroindene and spiroindane compounds
08/12/2009EP1379257B1 Prodrugs of anticancer agents employing substituted aromatic acids
08/12/2009EP1347753B3 Topical composition and method for treating urinary stress incontinence
08/12/2009EP1343760B1 Muscarinic antagonists
08/12/2009EP1294402B2 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds
1 ... 2624 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 ... 7860